Clinical Trial

A Prospective, Multicenter,Single-arm Study of DuoCor 2 Ventricular Assist System for the Treatment of Advanced Biventricular Heart Failure

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this clinical investigation is to evaluate the safety and efficacy of the DuoCor 2 Ventricular Assist System (DuoCor 2 VAS) in subjects with advanced biventricular heart failure requiring circulatory support. Each subject receiving the DuoCor 2 VAS will be evaluated at 6 months (180 days) for primary and secondary endpoints with further follow-up assessments up to 2 years.
Trial Details
NCT Number NCT07757451
Lead Sponsor Shenzhen Core Medical Technology CO.,LTD.
Conditions Advanced Heart Failure
Enrollment 64 participants
Start Date 2026-10
Primary Completion 2028-07 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11